Get tested with Superpower

If you’ve been postponing blood testing for years or feel frustrated by doctor appointments and limited lab panels, you are not alone. Standard healthcare is often reactive, focusing on testing only after symptoms appear or leaving patients in the dark.

Superpower flips that approach. We give you full insight into your body with over 100 biomarkers, personalized action plans, long-term tracking, and answers to your questions, so you can stay ahead of any health issues.

With physician-reviewed results, CLIA-certified labs, and the option for at-home blood draws, Superpower is designed for people who want clarity, convenience, and real accountability - all in one place.

Key benefits of Platelet-to-Lymphocyte Ratio testing

• Flags hidden inflammation that standard tests may miss in chronic conditions.
• Spots immune system imbalance linked to autoimmune disease or persistent infection.
• Guides cardiovascular risk assessment when combined with lipid and metabolic panels.
• Tracks treatment response in inflammatory bowel disease, rheumatoid arthritis, and lupus.
• Clarifies unexplained fatigue by revealing low-grade systemic inflammation.
• Supports cancer surveillance by detecting immune shifts during or after treatment.
• Best interpreted alongside complete blood count and inflammatory markers like CRP.

What is Platelet-to-Lymphocyte Ratio?

The platelet-to-lymphocyte ratio (PLR) is a calculated marker that compares the number of platelets to the number of lymphocytes in your blood. Platelets are tiny cell fragments made in your bone marrow that help form clots and stop bleeding. Lymphocytes are a type of white blood cell that coordinate your immune response against infections and abnormal cells.

A window into inflammation and immune balance

PLR reflects the balance between two opposing forces: clotting and inflammation (driven by platelets) versus immune regulation and defense (driven by lymphocytes). When this ratio shifts, it often signals that your body is responding to stress, infection, chronic inflammation, or immune dysregulation.

Why doctors track this simple calculation

Because PLR combines information from two different cell types, it captures a broader picture of your body's inflammatory and immune state than either measurement alone. It has emerged as a useful marker in cardiovascular disease, cancer, autoimmune conditions, and metabolic disorders, where the interplay between clotting tendency and immune function plays a central role.

Why is Platelet-to-Lymphocyte Ratio important?

The platelet-to-lymphocyte ratio (PLR) reflects the balance between clotting activity and immune regulation, offering a window into inflammation, immune health, and cardiovascular risk. Typical values range from 100 to 300, with optimal levels generally sitting in the lower half of that range. When this ratio shifts, it signals changes in how your body manages injury repair, infection defense, and chronic inflammatory stress.

When the ratio drops below normal

A low PLR usually means lymphocytes are elevated relative to platelets, often seen during active viral infections, autoimmune flares, or bone marrow disorders. This pattern suggests your immune system is highly activated or that platelet production is suppressed. You may feel fatigued, bruise easily, or notice swollen lymph nodes as your body redirects resources toward immune defense.

When the ratio climbs too high

An elevated PLR points to increased platelets, reduced lymphocytes, or both, commonly linked to chronic inflammation, cardiovascular disease, metabolic syndrome, and certain cancers. This imbalance can reflect smoldering arterial stress, insulin resistance, or immune exhaustion. Over time, it may contribute to clot formation, heart attack risk, and poor surgical or cancer outcomes.

The bigger inflammatory picture

PLR integrates signals from your bone marrow, immune system, and vascular health, making it a useful marker for tracking systemic inflammation and disease progression. It complements other inflammatory indices and helps clinicians assess long-term risk for thrombosis, metabolic disease, and immune dysfunction.

What do my Platelet-to-Lymphocyte Ratio results mean?

Low platelet-to-lymphocyte ratio

Low values usually reflect either reduced platelet production or elevated lymphocyte counts. This pattern can appear during viral infections when lymphocytes expand, in certain autoimmune conditions, or with bone marrow disorders that suppress platelet formation. It may also occur in chronic lymphocytic leukemia or after chemotherapy. A low ratio generally suggests less systemic inflammation but warrants investigation if persistent.

Optimal platelet-to-lymphocyte ratio

Being in range suggests balanced immune surveillance and normal platelet turnover. Most labs consider a ratio below 150 to 180 as normal, though optimal values typically sit in the lower half of this range. A stable ratio reflects appropriate coordination between clotting and immune systems, with neither excessive inflammation nor immune suppression.

High platelet-to-lymphocyte ratio

High values usually reflect increased systemic inflammation, elevated platelet production, or reduced lymphocyte counts. This pattern is common in chronic inflammatory states, active infections, cardiovascular disease, and many cancers. It can also appear with stress, smoking, metabolic syndrome, or after surgery. Elevated ratios correlate with worse outcomes in cardiovascular events and malignancies, serving as a marker of inflammatory burden rather than a specific diagnosis.

Factors that influence platelet-to-lymphocyte ratio

This ratio varies with acute illness, recent infection, medications that affect platelets or white cells, and physiologic stress. Pregnancy, older age, and chronic conditions all shift baseline values. Interpretation requires clinical context and trending over time.